Pierre Sokoloff
#167,048
Most Influential Person Now
Researcher
Pierre Sokoloff's AcademicInfluence.com Rankings
Pierre Sokoloffmathematics Degrees
Mathematics
#7548
World Rank
#10244
Historical Rank
Measure Theory
#2277
World Rank
#2729
Historical Rank
Pierre Sokoloffcomputer-science Degrees
Computer Science
#10124
World Rank
#10619
Historical Rank
Computational Linguistics
#2548
World Rank
#2573
Historical Rank
Machine Learning
#4615
World Rank
#4667
Historical Rank
Artificial Intelligence
#4979
World Rank
#5044
Historical Rank
Download Badge
Mathematics Computer Science
Pierre Sokoloff's Degrees
- PhD Computer Science Université Paris Cité
- Masters Computer Science Université Paris Cité
- Bachelors Mathematics Université Paris Cité
Similar Degrees You Can Earn
Why Is Pierre Sokoloff Influential?
(Suggest an Edit or Addition)Pierre Sokoloff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics (1990) (2523)
- Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA (1991) (867)
- Alternative splicing directs the expression of two D2 dopamine receptor isoforms (1989) (690)
- Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. (1992) (646)
- BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization (2001) (569)
- Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist (1999) (545)
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. (1992) (394)
- Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function (2003) (368)
- Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain (1995) (354)
- Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. (1997) (347)
- The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. (2006) (330)
- Dopamine D3 Receptors Expressed by All Mesencephalic Dopamine Neurons (2000) (323)
- Novel dopamine receptors half a decade later. (1995) (310)
- Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. (1985) (272)
- Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders (1992) (250)
- Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. (1992) (236)
- D3 dopamine receptor mRNA is widely expressed in the human brain (1998) (235)
- A functional test identifies dopamine agonists selective for D3 versus D2 receptors. (1995) (224)
- Molecular cloning and characterization of the rat fifth melanocortin receptor. (1994) (209)
- D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties* (2001) (208)
- Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions (2000) (196)
- A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning (2005) (188)
- The third dopamine receptor (D3) as a novel target for antipsychotics. (1992) (185)
- The dopamine D3 receptor and drug dependence: Effects on reward or beyond? (2005) (183)
- Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. (1995) (182)
- A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. (2006) (179)
- Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice (2002) (178)
- Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia (2000) (178)
- A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. (1995) (177)
- The dopamine D3 receptor, a quarter century later (2017) (165)
- Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions (1998) (158)
- Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. (1999) (155)
- The dopamine receptor family: molecular biology and pharmacology (1992) (154)
- Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments (2000) (151)
- Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats (2003) (148)
- Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence 1 Published on the World Wide Web on 24 November 1997. 1 (1998) (148)
- Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. (1991) (143)
- D3 receptor test in vitro predicts decreased cocaine self‐administration in rats (1997) (139)
- Involvement of the direct striatonigral pathway in levodopa‐induced sensitization in 6‐hydroxydopamine‐lesioned rats (2000) (131)
- Selective Expression of Dopamine D3 Receptor mRNA in Proliferative Zones during Embryonic Development of the Rat Brain (1997) (127)
- Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. (2005) (127)
- Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907 (1996) (126)
- Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. (1998) (124)
- Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. (1994) (124)
- Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus Accumbens (1994) (116)
- Localization and function of the D3 dopamine receptor. (1992) (110)
- Dopamine D3 receptor: basic and clinical aspects. (1993) (109)
- Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. (1993) (107)
- Glyceraldehyde-3-Phosphate Dehydrogenase Is a GABAA Receptor Kinase Linking Glycolysis to Neuronal Inhibition (2004) (106)
- Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence (1998) (105)
- Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene (1993) (104)
- Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects (2005) (103)
- Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. (2003) (99)
- Dopamine-related genes and their relationships to monoamine metabolites in CSF (1996) (98)
- N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands (2003) (91)
- Dopamine D3 receptor agents as potential new medications for drug addiction (2000) (91)
- 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors (1980) (87)
- A rat G protein‐coupled receptor selectively expressed in myelin‐forming cells (1998) (87)
- Dopamine D3 receptor gene variants and substance abuse in schizophrenia (1998) (83)
- Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels (2008) (82)
- Disruption of nicotine conditioning by dopamine D3 receptor ligands (2003) (81)
- Development of Novel 1,2,3,4‐Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands (2004) (81)
- No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. (1993) (80)
- Neurochemical Evidence that Postsynaptic Nucleus Accumbens D3 Receptor Stimulation Enhances Cocaine Reinforcement (1996) (78)
- Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. (1996) (78)
- The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade (2003) (77)
- GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling. (2004) (73)
- Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents (2009) (73)
- Modelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid (2008) (70)
- Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. (2008) (69)
- Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. (2003) (67)
- Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. (2005) (63)
- A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: No role in the genetic predisposition to bipolar affective disorder (1993) (62)
- Two Intracellular Signaling Pathways for the Dopamine D3 Receptor: Opposite and Synergistic Interactions with Cyclic AMP (1997) (61)
- CLIC6, a member of the intracellular chloride channel family, interacts with dopamine D(2)-like receptors. (2003) (58)
- Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral Tissues (1992) (58)
- Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. (2002) (57)
- Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. (2010) (55)
- The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and d -amphetamine and is not self-administered (2001) (55)
- No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees (1993) (53)
- Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C (1993) (51)
- Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. (2014) (51)
- Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia (2012) (50)
- Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families (2006) (50)
- Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. (1994) (50)
- Oligodendroglial Expression of Edg-2 Receptor: Developmental Analysis and Pharmacological Responses to Lysophosphatidic Acid (2002) (49)
- Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice (2004) (48)
- The dopamine D3 receptor and drug addiction (2001) (45)
- Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-Dihydroxyphenylalanine-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys (2004) (44)
- Immunohistological localization of the myelinating cell‐specific receptor LPA1 (2002) (42)
- Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. (2004) (42)
- Role of dopamine D3 receptors in thermoregulation: a reappraisal (2000) (41)
- Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells (1995) (41)
- Chromosomal localization of the human D3 dopamine receptor gene (1991) (41)
- Lack of association between alcohol-dependence and D3 dopamine receptor gene in three independent samples. (1995) (41)
- Brain-derived neurotrophic factor controls dopamine D3 receptor expression: Implications for neurodevelopmental psychiatric disorders (2009) (40)
- The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches (1995) (39)
- Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci1 (1993) (39)
- Dopamine D3 receptor ligands for the treatment of tobacco dependence (2007) (39)
- Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice (2018) (35)
- The D3 receptor and its relevance in psychiatry (1995) (29)
- A dopamine D3 receptor partial agonist blocks the expression of conditioned activity (2002) (29)
- The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist. (1995) (27)
- Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference (2004) (26)
- Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone (2004) (26)
- Subapical Localization of the Dopamine D3 Receptor in Proximal Tubules of the Rat Kidney (2004) (26)
- Exclusion of close linkage of bipolar disorder to the dopamine D3 receptor gene in nine Australian pedigrees. (1993) (25)
- Localization, regulation, and role of the dopamine D3 receptor are distinct from those of the D2 receptor. Discussion (1995) (25)
- Edg‐2 in myelin‐forming cells: Isoforms, genomic mapping, and exclusion in Charcot‐Marie‐Tooth disease (1999) (25)
- Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. (1990) (24)
- The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies. (1985) (22)
- Codistribution of the dopamine D3 receptor and glucocorticoid receptor mRNAs during striatal prenatal development in the rat (1997) (22)
- Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia (2019) (22)
- Identification of the dopamine autoreceptor in the guinea‐pig retina as D2 receptor using novel subtype‐selective antagonists (2001) (22)
- Antipsychotics with inverse agonist activity at the dopamine D3 receptor (2005) (20)
- Further evidence for the existence of opiate binding sites on neurosecretory LHRH mediobasal hypothalamic terminals. (1982) (20)
- Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor (2009) (20)
- Dopamine D3 receptor gene expression in the shell of nucleus accumbens is increased by chronic antidepressant treatment (2000) (19)
- D1/D3 receptor relationships in brain coexpression, coactivation, and coregulation. (1998) (19)
- Novel Dopamine Receptor Subtypes as Targets for Antipsychotic Drugs (1995) (19)
- Developmental and adult expression patterns of the G‐protein‐coupled receptor GPR88 in the rat: Establishment of a dual nuclear–cytoplasmic localization (2016) (18)
- Presence of dopamine D-2 receptors in human tumoral cell lines. (1989) (17)
- Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride. (1985) (17)
- Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites (1984) (17)
- 3H-domperidone binding sites differ in rat striatum and pituitary (1984) (16)
- Identification , characterization , and localization of the dopamine D 3 receptor in rat brain using 7-[ 3 H ] hydroxy-NN-din-propyl-2-aminotetralin ( guanine nucleotide-binding regulatory protein-coupled receptor / antipsychotics / islands of Calleja / cerebellum / nucleus accumbens ) (16)
- Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies (2009) (13)
- Multiple dopamine receptors: the D3 receptor and actions of substances of abuse. (1994) (13)
- Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist. (2020) (13)
- Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D3-receptor ligands (1999) (12)
- Functional models for the dopamine D3 receptor. (1996) (12)
- THE DOPAMINE D3 RECEPTOR AS A KEY TARGET FOR ANTIPSYCHOTICS (1992) (12)
- N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. (2003) (11)
- Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO (2019) (11)
- Clinical and functional correlates of a dopamine D3 receptor polymorphism (1995) (10)
- Dopaminergic Behavioral Responses and Classes of Binding Sites Distinguished by Discriminant Benzamide Derivatives (1986) (10)
- A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling (2016) (10)
- errata Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist (1999) (10)
- Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (9)
- Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation. (2010) (9)
- S.21.02 Evaluation of D3 receptor antagonists (1997) (9)
- Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology (1992) (9)
- N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands (2007) (9)
- The D3 Dopamine Receptor Gene as a Candidate Gene for Genetic Linkage Studies (1992) (8)
- Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides (1984) (8)
- The Third Dopamine Receptor (D3) as an Autoreceptor (1991) (8)
- Behavioral and neurochemical profiles of discriminant benzamide derivatives. Comment (1987) (7)
- [Function and therapeutic potential of the dopamine D3 receptor]. (1998) (6)
- Dopamine receptors: structure, function and implication in psychiatric disorders (2006) (6)
- Two D2 dopamine receptor isoforms generated via alternative mRNA splicing: regional distribution and effects of haloperidol treatments (1990) (6)
- New therapeutic targets to develop molecules active in drug‐resistant epilepsies (2010) (5)
- The Dopamine D3 Receptor and Its Implication in Neuropsychiatry Disorders and Their Treatments (2002) (5)
- Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia (2012) (5)
- Focus on clozapine: a new explanation for its atypical character. (2005) (5)
- Function and regulation of the D3 dopamine receptor (1993) (5)
- Two distinct classes of dopamine receptor mediating actions of antipsychotics: binding and behavioral studies. (1983) (4)
- 3H-Dopamine binding sites differ in rat striatum and pituitary. (1984) (3)
- High-resolution radioautographic study of dopamine binding sites in the rat neostriatum using 3H-domperidone. (1983) (3)
- Role of brain-derived neurotrophic factor in the control of D3 receptor expression (1999) (3)
- Mass Spectrometric Detection and Characterization of Atypical Membrane-Bound Zinc-Sensitive Phosphatases Modulating GABAA Receptors (2014) (3)
- Synthesis of S‐[3H]‐DO‐710, a benzamide ligand of the D2‐dopamine receptor and of S‐[3H]‐azidosulpride, its photoactivable analog (1987) (3)
- S10 BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) BRIDGES THE GAP BETWEEN DOPAMINE AND GLUTAMATE DYSFUNCTIONS IN SCHIZOPHRENIA (2004) (2)
- Effect of the D 3 Dopamine Receptor Partial Agonist BP 897 on L-Dopa-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys * (2004) (2)
- [Dopaminergic receptors, multiple targets for neuroleptics]. (1992) (2)
- Polymorphism of the dopamine D3 receptor gene associated with opioid dependence (1996) (2)
- 98-1 Implication of genes coding for dopamine receptors (D2 and D3) in alcohol dependence (1997) (1)
- The third dopamine receptor (D3): new perspectives in therapeutics. (1993) (1)
- 3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites (1985) (1)
- [Drugs acting on D3 receptors in neuropsychiatric disorders: facts and prospects. Implication for schizophrenia and its treatment in the regulation of BDNF-dependence on D3 receptor expression]. (2007) (1)
- A Historical Perspective on the Dopamine D3 Receptor. (2022) (1)
- S.04.01 Striatal synaptic and cortical nuclear orphan G protein-coupled receptor GPR88, a promising target for psychiatric and movement disorders (2008) (1)
- Negative Bias and Variability in Reflotron Capillary Cholesterol Determinations (1987) (1)
- Multiple Dopamine Receptors: Implications for Schizophrenia (1995) (1)
- High-Throughput Screening for Extracellular Inhibitors of the FLT3 Receptor Tyrosine Kinase Reveals Chemically Diverse and Druggable Negative Allosteric Modulators. (2022) (1)
- F17464 a new antipsychotic with preferential D3 antagonist, 5-HT1A partial agonist properties. Neurochemical studies (2017) (1)
- The Dopamine D3 Receptor in the Pathophysiology and Treatment of Neuropsychiatric Disorders (2003) (1)
- Heterocyclic Congeners of PD 128,907 with a Partially Hydrogenated Benzomorpholine Moiety as Potential Dopamine D3-Receptor Ligands. (2010) (1)
- New derivatives CHROMENES or thiochromenes carboxamides, their process for the preparation and their applications in therapeutics (2006) (0)
- Relationships between cerebrospinal fluid monoamine metabolites and dopamine-related genotypes in healthy volunteers (1995) (0)
- Derivatives of 3,4 - dihydro-2-naphthamide and therapeutic applications. (2006) (0)
- New tetracyclic piperidine and 1,4-oxazine (1995) (0)
- [Rationalizing the effect of antipsychotic agents]. (1999) (0)
- MAKING CONNECTIONS: ABNORMAL WHITE MATTER DEVELOPMENT IN THE EARLY STAGES OF SCHIZOPHRENIAChairperson: Marc L. SealSunday, 11 April, 2010 - 3:30 pm - 5:30 pm (2010) (0)
- Naphthamides derivatives, preparation method and its application in the therapeutic field. (1992) (0)
- CAFFEINE, IN THE FORM OF CAFFEINE-CONTAINING BEVERAGES OR OVER-THE-COUNTER CAFFEINE TAB- (2010) (0)
- Sensoryexperiencemodifies theshort-termdynamicsof neocortical synapses (0)
- Naphthamide, methods of preparation and their therapeutic application (1992) (0)
- THE ROLE OF CRAVING IN FAILURE OF DRUG DETOXIFICATION (1996) (0)
- Molecular Effects of Antidepressant Treatments (2008) (0)
- Novel 2-naphtanamidderivater and therapeutic uses thereof, as agonists of D 3 receptors (1996) (0)
- FLT3 signaling inhibition preserves opioid analgesia while abrogating tolerance and hyperalgesia (2023) (0)
- Chapter 29 Synaptic and Nuclear Localizations of the G Protein-Coupled Receptor GPR88 (2013) (0)
- BDNF, behavioral sensitization and schizophrenia (2001) (0)
- BDNF-Dependent Behavioral Sensitization in Hemiparkinsonian Rats (2002) (0)
- [Ultrastructural localization of dopaminergic receptors in the rat corpus striatum by radioautography using tritiated domperidone]. (1982) (0)
- Dopamine D3 receptor polymorphism and response to apomorphine challenge (1994) (0)
- Identification and functional assessment of small peptides antagonists of brain-derived neurotrophic factor (BDNF) (2006) (0)
- N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands. (2007) (0)
- New naphthamide derivative, its synthesis and its application for therapy (1992) (0)
- Distribution and Regulation of the G Protein- Coupled Receptor Gpr88 in the Striatum: Relevance to Parkinson’s Disease (2012) (0)
- Correction of dizocilpine-induced behavioral and biochemical abnormalities by dopamine D3 receptor blockade or invalidation in the mouse (2002) (0)
- Novel 2-naphthamides and their therapeutic applications as receptor agonists d3. (1996) (0)
- Polypeptides with human dopaminergic receptor, nucleic acids encoding such polypeptides and use of such polypeptides for screening active substances for such polypeptides. (1991) (0)
- The dopamine D3 receptor : developmental and psychiatric implications (1999) (0)
- Flt3 inhibitors for improving pain treatments by opioids (2018) (0)
- in skeletal muscle i ) 2+ increases (Ca Paraxanthine, a caffeine metabolite, dose dependently (2015) (0)
- Tetracyclic 1,4-oxazinderivater, process for their preparation and to pharmaceutical preparations which contain dis (1995) (0)
- New naphthamide derivatives and their therapeutic use as D3 receptor agonists (1996) (0)
- P.1.25 Striatal synaptic and cortical nuclear orphan G protein-coupled receptor GPR88, a promising target for psychiatric and movement disorders (2008) (0)
- Roles of the D3 receptor and brain-derived neurotrophic factor in behavioural sensitisation to psychomotor stimulants (2002) (0)
- The `Novel' Dopamine Receptors: Psychiatric Implications (1998) (0)
- Naphthamide derivatives, processes for their preparation as well as the implementation according to the therapeutic range (1992) (0)
- S.21.01 Function and regulation of the expression of the D3 receptor: Therapeutic implications (1997) (0)
- D1-D3 receptor interplay in schizophrenia: An hypothesis (1998) (0)
- Polypeptides with dopaminergic receptor, nucleic acids encoding these polypeptides and use of these polypeptides for the detection of active substances on these polypeptides. (1991) (0)
- P.5.011 Genes coding for dopamine receptors (D2 & D3) and alcohol dependence (1997) (0)
- P.1.04 Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors (2004) (0)
- Schwartz and Sokoloff reply: Selective agonists and antagonists are needed to determine a functional role for dopamine D3 receptors (1995) (0)
- 98-2 Involvement of amino acid serotoninergic mechanisms in the desire to drink in animal models (1997) (0)
- [Effect of S-adenosyl-L-homocysteine of dopamine catabolism]. (1979) (0)
- Rationaliser l'effet d'un antipsychotique. (1999) (0)
- Potential role of histamine in schizophrenia (1999) (0)
- Ave5997, a dopamine D3 antagonist for the treatment of schizophrenia (2003) (0)
- Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice (2018) (0)
- S.27.05 Nicotine and dopamine D3 receptor: Implications in drug addiction and Parkinson's disease (2003) (0)
- Dopamine D3 receptor agents in schizophrenia (1999) (0)
- ASSOCIATION OF D3 RECEPTOR GENE POLYMORPHISM WITH SCHIZOPHRENIA (1992) (0)
- The dopamine D3 receptor as a novel target for antipsychotics (1991) (0)
- The dopamine D3 receptor in nucleus accumbens: selective cellular localisation, function and regulation (1994) (0)
- Chromones derivatives, method of preparing them and their therapeutic applications (2009) (0)
- New derivatives of 2-naphtamides and therapeutic applications (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pierre Sokoloff?
Pierre Sokoloff is affiliated with the following schools:
